We leave our 2025E-27E sales unchanged after Q1 and lift EBITDA by SEK 5-8m for the same period as operating expenses were lower than we expected. Q1 demonstrated a fourth consecutive quarter with positive EBITDA (SEK 29m LTM now), which supports our previously stated view that Bactiguard has found operational stability. What is needed now for investor confidence to grow is better momentum with Zimmer and potential new deals.
LÄS MER
